Mometasone and Markers of Airway Inflammation

Completed · Phase 4 · Has a placebo group

Conditions studied: Asthma

In brief

A post-marketing study to look at the effects of Asmanex on markers of airway inflammation.

Key facts

Study ID

NCT00711165

Run by

Creighton University

People needed

12

Starts

2005-08-01

Expected to finish

2006-08-01

Last updated by the study team

2008-07-08

Who can join

Age: 19 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Asthma
• non-smoker
• FEV1 of at least 60% predicted

You may not qualify if…

• Pregnancy or lactation
• Corticosteroid use in past 30 days

Where it is running

• Creighton University Medical Center — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.